跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺维乐 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Sevelamer Carbonate Tablets
Approved
化学药品
Sevelamer Carbonate Tablets
GENZYME EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Aug 5, 2022
Approval ID
4a5445bc4fe10474
Company
GENZYME EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
4a5445bc4fe10474
Approval Number
国药准字HJ20181037
Generic Name
碳酸司维拉姆片
Generic Name En
Sevelamer Carbonate Tablets
Trade Name
诺维乐
Drug Type
化学药品
Dosage Form
片剂
Strength
800mg
Reg Date
2022-08-05
Expired Date
2027-08-04
Company Name
GENZYME EUROPE B.V.
Production Company Name
GENZYME IRELAND LIMITED
Company Detail Path
/organization/genzyme-europe-b-v
Production Company Detail Path
/organization/genzyme-ireland-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 5, 2022
Approval ID
4a5445bc4fe10474
Type
化学药品
Back to NMPA Approvals